Suzuki M, Hirasawa Y, Tanizawa T
Kidney Center, Shinrakuen Hospital, Niigata, Japan.
Clin Nephrol. 1995 Nov;44 Suppl 1:S51-5.
The aluminum (Al) contents of the tap water and the dialysis fluid in our center had proven to be less than 10 micrograms/l during more than 10 years. We evaluated the Al content, stainable Al, and the histomorphometry of the bone biopsy specimens from the 23 chronic renal failure patients on dialysis. The plasma Ca, P, Mg, ALP, C-PTH, and Al levels except calcitonin (CT, r = 0.442, p < 0.05) had no significant relationship to the hemodialysis (HD) duration. Their bone histologies were classified as osteitis fibrosa (OF) in 9, mild type (MILD) in 11, mixed type (MIXED) in 2, and osteomalacia (OM) in 1. The stainable Al% on the trabecular bone surface showed a positive correlation with HD duration (r = 0.569, p < 0.001), with the bone Al content (r = 0.455, p < 0.05), and with the bone Al/Ca ratio (r = 0.668, p < 0.01), respectively. The bone Al, Ca and Mg content did not correlated with HD duration and with plasma Al levels, although the bone Al/Ca ratio showed a strong correlation with HD duration (r = 0.675, p < 0.01) and with plasma Al levels (r = 0.719, p < 0.001). In the histomorphometric parameters, plasma Al levels, stainable Al, bone Al content, as well as bone Al/Ca ratio had no significant correlation with the osteomalacic aspects. Thus, our observations revealed that the Al accumulation in the bones was latent and progressing without definite osteomalacic changes, even though the dialysate Al concentration was under the critical level. Other Al invasion roots besides dialysis fluid should be regarded, including oral intake of Al-containing phosphate binders or other gastrointestinal medicines, as well as food content.
在过去十多年里,我们中心的自来水和透析液中的铝(Al)含量经证实均低于10微克/升。我们评估了23例接受透析的慢性肾衰竭患者骨活检标本的铝含量、可染色铝以及组织形态计量学指标。除降钙素(CT,r = 0.442,p < 0.05)外,血浆钙、磷、镁、碱性磷酸酶(ALP)、全段甲状旁腺激素(C-PTH)和铝水平与血液透析(HD)时长均无显著相关性。其骨组织学类型分为纤维性骨炎(OF)9例、轻度类型(MILD)11例、混合型(MIXED)2例、骨软化症(OM)1例。小梁骨表面的可染色铝百分比与HD时长(r = 0.569,p < 0.001)、骨铝含量(r = 0.455,p < 0.05)以及骨铝/钙比值(r = 0.668,p < 0.01)分别呈正相关。骨铝、钙和镁含量与HD时长及血浆铝水平均无相关性,尽管骨铝/钙比值与HD时长(r = 0.675,p < 0.01)和血浆铝水平(r = 0.719,p < 0.001)呈强相关。在组织形态计量学参数方面,血浆铝水平、可染色铝、骨铝含量以及骨铝/钙比值与骨软化症方面均无显著相关性。因此,我们的观察结果显示,尽管透析液铝浓度低于临界水平,但骨骼中的铝蓄积是潜在的且在进展,并无明确的骨软化症改变。应考虑除透析液之外的其他铝侵入途径,包括口服含铝的磷结合剂或其他胃肠道药物以及食物中的铝含量。